Cardiac Implantable Electronic Device (CIEDs) for Heart Failure in Indonesia: We Have to be More Selective
DOI:
https://doi.org/10.21776/ub.hsj.2020.001.02.1Keywords:
Cardiac Implantable Electronic Device, Heart failureAbstract
Cardiac Implantable Electronic Device (CIEDs) had been recommended as an integral part of heart failure management. Despite clear benefits on CIEDs itself, the rate of therapy penetration in Indonesia is still very low. Many contributing factors had been identified, they are lack of physician awareness, lack of referral, and mismatch between national insurance reimbursement and the cost of therapy. We focussed on talking about selective patient selection as one of the most feasible solutions to this problem.References
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureThe Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016 Jul 14;37(27):2129–200.
Cardiac Resynchronization Therapy: History, Present Status, and Future Directions [Internet]. [cited 2020 Jul 8]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295737/
Gama Francisco, Ferreira Jorge, Carmo João, Costa Francisco Moscoso, Carvalho Salomé, Carmo Pedro, et al. Implantable Cardioverter–Defibrillators in Trials of Drug Therapy for Heart Failure: A Systematic Review and Metaâ€Analysis. J Am Heart Assoc. 2020 Apr 21;9(8):e015177.
Park MY, Altman RK, Orencole M, Kumar P, Parks KA, Heist KE, et al. Characteristics of Responders to Cardiac Resynchronization Therapy: The Impact of Echocardiographic Left Ventricular Volume. Clin Cardiol. 2012 Aug 9;35(12):779–80.
Authors/Task Force Members, Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013 Aug 1;15(8):1070–118.
Van Bommel RJ, Bax JJ, Abraham WT, Chung ES, Pires LA, Tavazzi L, et al. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J. 2009 Oct 1;30(20):2470–7.
Predictors of Appropriate Shocks and Ventricular Arrhythmia in Indonesian with Brugada Syndrome. Indones J Cardiol [Internet]. 2019 Sep 11 [cited 2020 Jul 16];40(2). Available from: https://www.ijconline.id/index.php/ijc/article/view/767
Society APHR: The aphrs white book 2019. http://aphrsorg/publicationshtml (2019). 2019;0:0–0
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
